(Q39390992)

11 September 2017

title

AR-Q640X, a model to study the effects of constitutively active C-terminally truncated AR variants in prostate cancer cells (English)

1 reference

11 September 2017

Wolfgang Streicher

1

1 reference

11 September 2017

Friedemann Zengerling

2

1 reference

11 September 2017

Martin Laschak

3

1 reference

11 September 2017

Wolfgang Weidemann

4

1 reference

11 September 2017

Michael Höpfner

5

1 reference

11 September 2017

Andres J Schrader

6

1 reference

11 September 2017

Florian Jentzmik

7

1 reference

11 September 2017

Mark Schrader

8

1 reference

11 September 2017

Marcus V Cronauer

9

1 reference

11 September 2017

publication date

24 February 2012

1 reference

11 September 2017

published in

World Journal of Urology

1 reference

11 September 2017

volume

30

1 reference

11 September 2017

issue

3

1 reference

11 September 2017

page(s)

333-339

1 reference

11 September 2017

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS00345-012-0842-0

In vivo amplification of the androgen receptor gene and progression of human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-012-0842-0

Constitutive activation of the androgen receptor by a point mutation in the hinge region: a new mechanism for androgen-independent growth in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-012-0842-0

Evidence for calpain-mediated androgen receptor cleavage as a mechanism for androgen independence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-012-0842-0

Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-012-0842-0

Androgen receptor and its splice variants in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-012-0842-0

Resistance to CYP17A1 inhibition with abiraterone in castration-resistant prostate cancer: induction of steroidogenesis and androgen receptor splice variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-012-0842-0

Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-012-0842-0

Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-012-0842-0

Inhibition of glycogen synthase kinase-3β counteracts ligand-independent activity of the androgen receptor in castration resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-012-0842-0

Androgen responsiveness of Renilla luciferase reporter vectors is promoter, transgene, and cell line dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-012-0842-0

Domains of the Human Androgen Receptor Involved in Steroid Binding, Transcriptional Activation, and Subcellular Localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-012-0842-0

Ligand-independent androgen receptor variants derived from splicing of cryptic exons signify hormone-refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-012-0842-0

A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-012-0842-0

Expression of androgen receptor splice variants in prostate cancer bone metastases is associated with castration-resistance and short survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-012-0842-0

Androgen receptor variants occur frequently in castration resistant prostate cancer metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-012-0842-0

A snapshot of the expression signature of androgen receptor splicing variants and their distinctive transcriptional activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-012-0842-0

Pleiotropic functional properties of androgen receptor mutants in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-012-0842-0

Regression of castrate-recurrent prostate cancer by a small-molecule inhibitor of the amino-terminus domain of the androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00345-012-0842-0

Distant metastases from prostatic carcinoma express androgen receptor protein.

21 January 2018

1 reference

12 December 2020

Specific properties of a C-terminal truncated androgen receptor detected in hormone refractory prostate cancer

1 reference

12 December 2020

Characterization of two cis-acting DNA elements involved in the androgen regulation of the probasin gene

1 reference

12 December 2020

Mechanisms of persistent activation of the androgen receptor in CRPC: recent advances and future perspectives

1 reference

12 December 2020

Androgen receptor status of lymph node metastases from prostate cancer

1 reference

12 December 2020

The androgen receptor in hormone-refractory prostate cancer: relevance of different mechanisms of androgen receptor signaling (Review).

1 reference

12 December 2020

Characterization of a novel androgen receptor mutation in a relapsed CWR22 prostate cancer xenograft and cell line

1 reference

12 December 2020

10.1007/S00345-012-0842-0

Identifiers

DOI

1 reference

11 September 2017

1 reference